Wednesday, August 27th, 2025
Stock Profile: AVTE
AVTE Logo

Aerovate Therapeutics, Inc. (AVTE)

Market: NASD | Currency: USD

Address: 930 Winter Street

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.




📈 Aerovate Therapeutics, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2025 - $0.028571 - 2025-04-29 - Stock split
$2.400000 - 2025-04-25 - Dividend payout
Total Amount for 2025: $2.428571


📅 Earnings & EPS History for Aerovate Therapeutics, Inc.


DateReported EPS
2025-04-25-3.15
2025-02-24-6.65
2024-11-12-19.6
2024-08-12-30.1
2024-05-13-29.05
2024-03-25-25.9
2023-11-13-24.85
2023-08-14-26.6
2023-05-15-23.45
2023-03-29-21.35
2022-11-14-19.6
2022-08-15-17.15
2022-05-16-15.75
2022-03-30-2.45
2021-11-15-9.1
2021-08-16-8.28




📰 Related News & Research


No related articles found for "aerovate therapeutics".